APA

Borgohain R., Szasz J., Stanzione P., Meshram C., Bhatt M. H., Chirilineau D., Stocchi F., Lucini V., Giuliani R., Forrest E., Rice P. & Anand R. (20150514). Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease. : Movement disorders : official journal of the Movement Disorder Society.

Chicago

Borgohain Rupam, Szasz Jozsef, Stanzione Paolo, Meshram Chandrashekhar, Bhatt Mohit H, Chirilineau Dana, Stocchi Fabrizio, Lucini Valentina, Giuliani Rodolfo, Forrest Emma, Rice Patricia and Anand Ravi. 20150514. Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease. : Movement disorders : official journal of the Movement Disorder Society.

Harvard

Borgohain R., Szasz J., Stanzione P., Meshram C., Bhatt M. H., Chirilineau D., Stocchi F., Lucini V., Giuliani R., Forrest E., Rice P. and Anand R. (20150514). Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease. : Movement disorders : official journal of the Movement Disorder Society.

MLA

Borgohain Rupam, Szasz Jozsef, Stanzione Paolo, Meshram Chandrashekhar, Bhatt Mohit H, Chirilineau Dana, Stocchi Fabrizio, Lucini Valentina, Giuliani Rodolfo, Forrest Emma, Rice Patricia and Anand Ravi. Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease. : Movement disorders : official journal of the Movement Disorder Society. 20150514.